Serum copper in ovarian carcinoma

Allan J. Jacobs; Gara M. Sommers; Janice H. Axelrod; Andrew E. Galakatos; Ming‐Shian ‐S Kao; H. Marvin Camel

doi:10.1002/1097-0142(19880301)61:5<1015::AID-CNCR2820610526>3.0.CO;2-T

Serum copper in ovarian carcinoma

Allan J. Jacobs, Gara M. Sommers, Janice H. Axelrod, Andrew E. Galakatos, Ming‐Shian ‐S Kao, H. Marvin Camel

Department of Obstetrics & Gynecology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.

Original language	English
Pages (from-to)	1015-1017
Number of pages	3
Journal	Cancer
Volume	61
Issue number	5
DOIs	https://doi.org/10.1002/1097-0142(19880301)61:5<1015::AID-CNCR2820610526>3.0.CO;2-T
State	Published - Mar 1 1988

Access to Document

10.1002/1097-0142(19880301)61:5<1015::AID-CNCR2820610526>3.0.CO;2-T

Cite this

@article{b51d034fa8564c8d9fc2480853de48d2,

title = "Serum copper in ovarian carcinoma",

abstract = "The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.",

author = "Jacobs, {Allan J.} and Sommers, {Gara M.} and Axelrod, {Janice H.} and Galakatos, {Andrew E.} and Kao, {Ming‐Shian ‐S} and Camel, {H. Marvin}",

year = "1988",

month = mar,

day = "1",

doi = "10.1002/1097-0142(19880301)61:5<1015::AID-CNCR2820610526>3.0.CO;2-T",

language = "English",

volume = "61",

pages = "1015--1017",

journal = "Cancer",

issn = "0008-543X",

number = "5",

}

TY - JOUR

T1 - Serum copper in ovarian carcinoma

AU - Jacobs, Allan J.

AU - Sommers, Gara M.

AU - Axelrod, Janice H.

AU - Galakatos, Andrew E.

AU - Kao, Ming‐Shian ‐S

AU - Camel, H. Marvin

PY - 1988/3/1

Y1 - 1988/3/1

N2 - The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.

AB - The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.

UR - http://www.scopus.com/inward/record.url?scp=0023856216&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19880301)61:5<1015::AID-CNCR2820610526>3.0.CO;2-T

DO - 10.1002/1097-0142(19880301)61:5<1015::AID-CNCR2820610526>3.0.CO;2-T

M3 - Article

C2 - 3422179

AN - SCOPUS:0023856216

SN - 0008-543X

VL - 61

SP - 1015

EP - 1017

JO - Cancer

JF - Cancer

IS - 5

ER -

Serum copper in ovarian carcinoma

Abstract

Access to Document

Other files and links

Fingerprint

Cite this